Comparison between Modern Diagnostic IPO and Swastika Castal IPO.
Modern Diagnostic IPO is a SME Fixed Price IPO proposed to list at BSE SME while Swastika Castal IPO is a SME Fixed Price proposed to list at BSE SME.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Accurate Securities & Registry Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Horizon Financial Consultants Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Modern Diagnostic IPO is up to ₹0.00 Cr whereas the issue size of the Swastika Castal IPO is up to ₹13.35 Cr. The final issue price of Modern Diagnostic IPO is and of Swastika Castal IPO is ₹65.00 per share.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹65.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | |
| Fresh Issue Size | 41,00,000 shares | 20,54,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹13.35 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 41,00,000 shares | 20,54,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹13.35 Cr |
Modern Diagnostic IPO opens on , while Swastika Castal IPO opens on Jul 21, 2025. The closing date of Modern Diagnostic IPO and Swastika Castal IPO is , and Jul 23, 2025, respectively.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 21, 2025 | |
| Issue Close | Jul 23, 2025 | |
| Basis Of Allotment (Tentative) | Jul 24, 2025 | |
| Initiation of Refunds (Tentative) | Jul 25, 2025 | |
| Credit of Share (Tentative) | Jul 25, 2025 | |
| Listing date (Tentative) | Jul 28, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Modern Diagnostic IPO P/E ratio is , as compared to Swastika Castal IPO P/E ratio of 14.8.
| Modern Diagnostic IPO | Swastika Castal IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Modern Diagnostic & Research Centre Limited Financial Information (Restated)
| Swastika Castal Ltd. Financial Information (Restated)Swastika Castal Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 305% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹53.07 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 65.40% | 28.17% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 25.58% | 32.74% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.74 | 0.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 49.28% | 24.70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Modern Diagnostic IPO Retail Individual Investors (RII) are offered while in Swastika Castal IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Modern Diagnostic IPO and 0 shares in Swastika Castal IPO.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,10,000 shares | |
| QIB | 0 shares | |
| NII | 10,26,000 shares | |
| RII | 10,28,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 20,54,000 shares |
Modern Diagnostic IPO subscribed in total, whereas Swastika Castal IPO subscribed 5.08x.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.42x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.75x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 5.08x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
